1-8 of 8
Xindi Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BTK Inhibitor Synergizes with CD19-Targeted Chimeric Antigen Receptor-T Cells in Patients with Relapsed or Refractory B-Cell Lymphoma: An Open-Label Pragmatic Clinical Trial

Wenjing Luo, Yinqiang Zhang, Chenggong Li, Jia Xu, Wu Zhuolin, Xindi Wang, Yun Kang, Danying Liao, Haiming Kou, Wei Xie, Wei Xiong, Jun Deng, Yu Hu, Heng Mei
Journal: Blood
Blood (2024) 144 (Supplement 1): 6546.
https://doi.org/10.1182/blood-2024-205304
Published: 2024
Journal Articles

Prior Antibiotic Exposure Correlates with Unfavorable Efficacy and Prognosis of B-NHL after CAR-T Cell Therapy

Jia Xu, Wenjing Luo, Chenggong Li, Yinqiang Zhang, Xindi Wang, Jiachen Liu, Wu Zhuolin, Zhongpei Huang, Yun Kang, Qiaolin Liu, Zhihan Chen, Heng Mei
Journal: Blood
Blood (2024) 144 (Supplement 1): 7158.
https://doi.org/10.1182/blood-2024-209107
Published: 2024
Journal Articles

Natural Killer-Cell Recovery in Patients Receiving CD19 CAR T-Cell Therapy: Dynamics and Clinical Significance

Xindi Wang, Wenjing Luo, Lu Tang, Yu Hu, Heng Mei
Journal: Blood
Blood (2024) 144 (Supplement 1): 7217.
https://doi.org/10.1182/blood-2024-205259
Published: 2024
Journal Articles

Co-Expression of IL-15 and CCL21 Strengthens CAR-NK Cells to Eliminate Tumors in Concert with T Cells and Equips Them with Higher PI3K/AKT/mTOR Signal Signature

Xindi Wang, Wenjing Luo, Zhaozhao Chen, Yu Hu, Heng Mei
Journal: Blood
Blood (2024) 144 (Supplement 1): 4816.
https://doi.org/10.1182/blood-2024-205045
Published: 2024
Journal Articles

Selinexor Reduces the Immunosuppressive Properties of Macrophages and Synergizes with CD19 CAR-T Cells Against B-Cell Lymphoma

Wenjing Luo, Jia Xu, Chenggong Li, Lu Tang, Yingying Li, Xindi Wang, Wu Zhuolin, Yinqiang Zhang, Yu Hu, Heng Mei
Journal: Blood
Blood (2024) 144 (Supplement 1): 3420.
https://doi.org/10.1182/blood-2024-207202
Published: 2024
Journal Articles

BTK Inhibitors Improve CART19 Cell Therapy By Modulating Immune System

Wenjing Luo, Chenggong Li, Jianghua Wu, Yinqiang Zhang, Lu Tang, Mengyi Du, Xindi Wang, Wei Xiong, Haiming Kou, Cong Lu, Heng Mei, Yu Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10294–10295.
https://doi.org/10.1182/blood-2022-170898
Published: 2022
Journal Articles

Autophagy Facilitates Cancer-Intrinsic Evasion of CAR T Cell-Mediated Cytotoxicity in B-Cell Malignancies

Heng Mei, Lu Tang, Huan Zhang, Fen Zhou, Mengyi Du, Jianghua Wu, Chenggong Li, Qiuzhe Wei, Wenjing Luo, Yinqiang Zhang, Xindi Wang, ZhaoZhao Chen, Jie Zhou, Zhuolin Wu, Zhongpei Huang, Yuxi Wen, Huiwen Jiang, Danying Liao, Haiming Kou, Yu Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 634–635.
https://doi.org/10.1182/blood-2022-168590
Published: 2022
Journal Articles

Bispecific CS1-BCMA CAR-T Cells Are Clinically Active in Relapsed or Refractory Multiple Myeloma: An Updated Clinical Study

Chenggong Li, Xindi Wang, Zhuolin Wu, Wenjing Luo, Yinqiang Zhang, Yun Kang, Jia Xu, Zhongpei Huang, Mengyi Du, Lu Tang, Jianghua Wu, Danying Liao, Haiming Kou, Cong Lu, Huiwen Jiang, Qiuzhe Wei, Sha Ke, Jing'e Zheng, Wei Xiong, Jun Deng, Yu Hu, Heng Mei
Journal: Blood
Blood (2022) 140 (Supplement 1): 4573–4574.
https://doi.org/10.1182/blood-2022-170686
Published: 2022